Ignite Creation Date:
2024-10-26 @ 3:39 PM
Last Modification Date:
2024-10-26 @ 3:39 PM
Study NCT ID:
NCT06574646
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-08-09
Brief Title:
Visual Acuity Outcome Differences Between the Alcon Vivity Toric IOL and RxSight LAL
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Visual Acuity Outcome Differences Between the Alcon Vivity Toric IOL and RxSight LAL
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Phase 1 will be ambispective multi-site single arm study in age-related cataract patients with regular astigmatism who were bilaterally treated with the LAL IOLs
Phase 2 will be a prospective randomized unmasked comparative multi-site study with 90 days of follow up Subjects will be randomized in a 11 manner to LAL or Clareon VIvity Toric IOLs
Phase 2 will be a prospective randomized unmasked comparative multi-site study with 90 days of follow up Subjects will be randomized in a 11 manner to LAL or Clareon VIvity Toric IOLs
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None